DoP asks NPPA to review, verify Bharat Serum and Vaccine's
The Department of Pharmaceuticals (DoP) has issued an order disposing the review application of Bharat Serum and Vaccine (BSVL) to the National Pharmaceutical Pricing Authority (NPPA) instructing to verify the applicability of GST factor by cross-checking the documents submitted by BSVL pertaining to the formulation Human Normal Immunoglobulin.
DoP asks NPPA to review prices fixed for Eli Lilly’s insulin
The company first sought review with the NPPA on July 30, 2012. “While examining the said review application, the Department observed and recommended that as per Para 1 (b)(vi) of the Guideline No 1/99, NPPA has amended the words “shall not exceed 50 per cent to 35 per cent.
DoP asks NPPA to review, verify Bharat Serum and Vaccine’s
You are here: Industry Insights > Market News > DoP asks NPPA to review, ... Hydroxypropyl-Beta-Cyclodextrin CAS 128446-35-5 Pharmaceutical grade hydroxypropyl betadex.
DoP junks Skymap Pharma review plea against NPPA
New Delhi: In a major setback to Skymap Pharmaceuticals Limited, the Department of Pharmaceuticals (DoP) has rejected the review application filed by the drugmaker against a notification issued by the National Pharmaceutical Pricing Authority (NPPA) for fixing the retail price of Fluconazole Tablets 300mg.
DoP asks NPPA to revise prices of chloroquine phosphate
The department of pharmaceuticals (DoP) has directed the National Pharmaceutical Pricing Authority (NPPA) to revise the prices of chloroquine phosphate injection (40mg/ml- 64.5mg eq to 40mg chloroquine) and metronidazole 200 mg & metronidazole 400 mg tablets.
